“If the particulate matter enters the blood vessels, it can travel to various organs and potentially block blood vessels in the heart, lungs or brain, leading to serious complications such as stroke or even death ,” the statement said. This drug is used to deal with the lowering of blood pressure under anesthesia.
US berry-related outbreaks of intestinal viruses such as hepatitis A and norovirus have been linked to imported rather than domestic fresh and frozen berries.
Liberty-based Vitti Labs, a human tissue bank, is suing the Food and Drug Administration over how the agency is regulating a product derived from umbilical cords. Vitti filed a lawsuit against the FDA on Jan. 7, challenging how it classifies a Vitti Labs product called Cordgraft.
Republicans, on the other hand, were twice as likely to trust Trump (84%), Kennedy (81%), and Mehmet Oz (83%) — who is Trump’s nominee to lead the Center for Medicaid and Medicare Services. Less than 20% of Democrats trusted these individuals.
Zyn products will be allowed to stay on the market after federal health officials said Thursday that the popular nicotine pouches can help adult smokers cut back or switch completely.
According to the KDHE, there have been 67 active cases of TB tied to the outbreak in the Kansas City, Kansas ... Trump Orders CDC, FDA, and Other Health Agencies to Go Dark Globally, experts ...
With the big game on the horizon, many are planning their menus for Super Bowl Sunday. But if your shopping list contains Lay’s potato chips, there is some information you need
As of January 2025, the Kansas City Chiefs have firmly established themselves as a dominant force in the NFL, boasting four Super Bowl victories in their franchise history. Central
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
A D.C. drugmaker is fighting the FDA on multiple fronts, from trying protect its intellectual property from generic competition to battles over getting more drugs to market.
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce certain risks associated with chronic kidney disease.